Back to Test Catalogue

Vitamin B3, Serum/Plasma

Test ID: VITB3

Test

Aliases/Synonyms

Nicotinamide; Nicotinic Acid; Niacin

Method

Chromatography/Mass Spectrometry

Report Includes

Nicotinamide; Nicotinic Acid

Specimens

Gel-separator tubes are not acceptable; Serum; Plasma

Test Location

Quest Diagnostics, California USA

Test Version

20-Sep-2022

Specimen

Specimens

Gel-separator tubes are not acceptable; Serum; Plasma

Collection Containers

Preferred

Red top (No additive)

Acceptable

Lavender top (EDTA)

Sample Volume

1.0 mL

Minimum Volume

0.5 mL

Specimen Comment

Avoid gel-separator tubes.

Collection & Handling

Handling Information

Store and submit specimen protected from light in an amber vial.
Store and send frozen.

Stability

Ambient Unacceptable
Refrigerated Unacceptable
Frozen 30 days

Rejection Criteria

Specimen Gel tube or not protected from light

Test Version

20-Sep-2022

Performance / Interpretation

Method

Chromatography/Mass Spectrometry

Turnaround Time

7 days

Results

Name Units Reference Range Conversion Factor
Nicotinamide ng/mL
Nicotinamide is a metabolite of nicotinic acid. Due to the large variability in the metabolism of nicotinic acid, plasma concentrations of this metabolite are variable. In one study, fasting plasma concentrations were reported to be approximately 40 ng/mL. In another study it was reported that the administration of a single 1000 mg of extended-release tablet of nicotinic acid resulted in a mean peak nicotinamide concentration of 400 ng/mL between 5 and 10 hours post dose, decreasing to about 100 ng/mL by 16 hours post dose.
Nicotinic Acid ng/mL
Due to the large variability in the metabolism of nicotinic acid, the dosing preparation used (immediate-release vs. extended release), and the mg doses used, the serum concentrations may range from less than 20 ng/mL to about 30,000 ng/mL. After oral administration of an immediate-release tablet, peak plasma concentrations occur in 4 to 5 hours. The plasma half-life of nicotinic acid is about one hour. In one study, fasting plasma concentrations were reported to be less than 20 ng/mL. In another study, it was reported that the administration of a single 1000 mg extended-release tablet resulted in mean nicotinic acid concentrations of less than 50 ng/mL.

Test Location

Quest Diagnostics, California USA

Test Version

20-Sep-2022

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
VITB3 62652NICOTINIC ACID ng/mL
62653NICOTINAMIDE ng/mL

Test Version

20-Sep-2022